MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202541031191 A) filed by Rk Pharma Inc on March 29, 2025, for “ready-To-Use Formulations (rtu) Of Vosoritide And Its Manufacturing Methods Thereof”.
Inventors include Ravishanker Kovi; and Vure Prasad.
The application for the patent was published on October 02, 2026, under issue no. 40/2026.
Abstract: “READY-TO-USE FORMULATIONS (RTU) OF VOSORITIDE AND ITS MANUFACTURING METHODS THEREOF” The present invention relates to Ready-To- Use Formulations (RTU) of Vosoritide. The present invention further relates to pharmaceutical formulation comprising Vosoritide and pharmaceutically acceptable excipients. The present invention further relates to pharmaceutical formulation comprising Vosoritide and pharmaceutically acceptable excipients for parenteral administration using a vial, pre-filled syringe, pre-filled syringe with a device or autoinjector. The present invention provides a polymer based single or dual bag for the intravenous administration of Vosoritide wherein it contains Vosoritide ready-to-administer for parenteral administration. Formula 1
Disclaimer: Curated by HT Syndication.
